DEFINITIVE PROXY

Company

Theriva Biologics, Inc.

Filed

June 23, 1998

Period of Report

July 15, 1998

Accession Number

0000921895-98-000560

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →